Company Search:
Advanced Search
Sponsored Links
Heidelberg Pharma Ag Company Snapshot
Heidelberg Pharma Ag operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Heidelberg Pharma Ag with three other companies in this sector in Germany: 4Sc AG (2018 sales of 4.17 million Euro [US$4.60 million] ), Mologen AG (3.05 million Euro [US$3.36 million] of which 100% was Goods & Services), and Northern Bitcoin AG (2.57 million Euro [US$2.83 million] ).

Sales Analysis. Heidelberg Pharma Ag reported sales of 3.67 million Euro (US$4.04 million) for the fiscal year ending November of 2018. This represents an increase of 93.0% versus 2017, when the company's sales were 1.90 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Heidelberg Pharma Ag
  Stock Performance Chart for Heidelberg Pharma Ag
  Stock Data: Recent Stock Performance:
  Current Price (11/8/2019): 2.16
(Figures in Euro)
1 Week 1.9%   13 Weeks -2.3%  
4 Weeks -13.6%   52 Weeks -13.3%  
Heidelberg Pharma Ag Key Data:
  Ticker: WL6 Country: Germany
  Exchanges: FRA Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 3,667,812
(Year Ending Jan 2019).
Employees: 60
  Currency: Euro Market Cap: 60,821,312
  Fiscal Yr Ends: November Shares Outstanding: 28,158,015
  Share Type: Stammaktie Closely Held Shares: 22,246,449
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.